Search Results

Thomas Olin, chief executive officer of Kancera, took time to discuss the company, the Fracktalkine pathway and the upcoming clinical trial.

Oncopeptides AB (Nasdaq Stockholm: ONCO) announces today that the Company has agreed with Kancera to take over Kancera’s drug development facility in Solna, Sweden . The agreement is an important step in the development of Oncopeptides’ pre-clinical operations and marks an additional reinforcement of the Company’s research capacity

Kancera AB is seeing encouraging results from its Phase 1 study with its Lead Immunoregulating Drug Candidate KAND567.

XNK Therapeutics AB announced the appointment of Markus Thor as Chief Business Officer, effective September 6th.

Companies from across Europe and Asia share updates on their business and pipelines.

Biopharma and life sciences companies from across the globe provide updates on their pipelines and business operations.

Companies from across the globe provide updates on their business and pipelines.

Please check out the biopharma industry coronavirus (COVID-19) stories that are trending for July 15, 2020.

Non-COVID-19 clinical trial updates are outweighing COVID-19 studies, particularly with the American Society of Clinical Oncology meeting coming up soon. Here’s a look.